Evidence map›Paper›PMID 34381570›Full record

ArticleOncotarget2021

Correction: Cbl-b inhibits P-gp transporter function by preventing its translocation into caveolae in multiple drug-resistant gastric and breast cancers.

Ye Zhang, Xiujuan Qu, Yuee Teng, Zhi Li, Ling Xu, Jing Liu, Yanju Ma, Yibo Fan, Ce Li, Shizhou Liu and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Ye ZhangDepartment of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.
Xiujuan QuDepartment of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.
Yuee TengDepartment of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.
Zhi LiDepartment of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.
Ling XuDepartment of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.
Jing LiuDepartment of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.
Yanju MaDepartment of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.
Yibo FanDepartment of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.
Ce LiDepartment of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.
Shizhou LiuDepartment of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.
Zhenning WangDepartment of Surgical Oncology and General Surgery, the First Hospital of China Medical University, Shenyang 110001, China.
Xuejun HuDepartment of Medical Respiratory, the First Hospital of China Medical University, Shenyang 110001, China.
Jingdong ZhangDepartment of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.
Yunpeng LiuDepartment of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.18632/oncotarget.3253.].

Identifiers

PMID34381570
PMCPMC8351607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.